Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Komminoth

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
International Journal of Cancer|October 7, 1998
Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomasE van der Harst, R R de Krijger, H A Bruining, et al.
The American Journal of Pathology|May 4, 2000
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumorsO Gimm, A Perren, L P Weng, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumorsD J Marsh, Z Zheng, A Arnold, et al.
Virchows Archiv : an International Journal of Pathology|September 13, 2006
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemG Rindi, G Klöppel, H Alhman, et al.
Der Pathologe|March 28, 2014
[Neuroendocrine neoplasms of the distal jejunum and ileum]M Anlauf, B Sipos, I Boeck, et al.
Journal of the National Cancer Institute|April 25, 2012
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort studyG Rindi, M Falconi, C Klersy, et al.
JAMA|November 20, 1996
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisC Eng, D Clayton, I Schuffenecker, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
International Journal of Cancer|October 7, 1998
Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomasE van der Harst, R R de Krijger, H A Bruining, et al.
The American Journal of Pathology|May 4, 2000
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumorsO Gimm, A Perren, L P Weng, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumorsD J Marsh, Z Zheng, A Arnold, et al.
Virchows Archiv : an International Journal of Pathology|September 13, 2006
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemG Rindi, G Klöppel, H Alhman, et al.
Der Pathologe|March 28, 2014
[Neuroendocrine neoplasms of the distal jejunum and ileum]M Anlauf, B Sipos, I Boeck, et al.
Journal of the National Cancer Institute|April 25, 2012
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort studyG Rindi, M Falconi, C Klersy, et al.
JAMA|November 20, 1996
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisC Eng, D Clayton, I Schuffenecker, et al.
Pageof 12